AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Medistep Healthcare IPO: GMP at 40%, Issue Size at Rs 16.10 Cr, and Listing Expected on Aug 18
ByAinvest
Thursday, Aug 7, 2025 10:20 pm ET1min read
Medistep Healthcare, an Ahmedabad-based pharmaceutical and wellness products company, is set to open its Rs 16.10 crore IPO on August 8, with the issue closing on August 12. The issue price is fixed at Rs 43 per share, and shares are scheduled to list on August 18, 2025. The grey market premium has surged to 40% over the issue price, signalling strong investor appetite and potential for upside on debut. The company plans to use IPO proceeds to fund plant and machinery purchases, meet working capital needs, and for general corporate purposes.
Medistep Healthcare, an Ahmedabad-based pharmaceutical and wellness products company, is set to open its Rs 16.10 crore Initial Public Offering (IPO) on August 8, with the issue closing on August 12. The issue price is fixed at Rs 43 per share, and shares are scheduled to list on August 18, 2025 [1].The company has generated significant market interest, with the grey market premium (GMP) surging to 40% over the issue price. This surge indicates strong investor appetite and potential for upside on debut. The grey market premium has reached Rs 17, implying an implied listing price of around Rs 60 per share [1].
Medistep Healthcare specializes in manufacturing and trading a range of products, including sanitary pads (DryStep brand), energy powder (VitaStep Z), nutraceuticals, pharmaceuticals, and intimate and surgical products. The company aims to scale its manufacturing and trading verticals post-listing [1].
The IPO comprises a 100% fresh issue of 37.44 lakh equity shares, with no offer for sale component. The issue is being led by Fast Track Finsec as the book-running lead manager, while Cameo Corporate Services is the registrar [1].
Medistep Healthcare reported revenues of Rs 49.66 crore in FY25, a 27% year-over-year (YoY) increase, with PAT at Rs 4.14 crore, up 25%. The company intends to use IPO proceeds to fund plant and machinery purchases, meet working capital needs (Rs 12.34 crore), and for general corporate purposes [1].
The IPO is a Fixed Price Issue, with a price band of Rs 43 per share. The retail quota is 50%, QIB is 0%, and HNI is 50%. The IPO listing is scheduled on the NSE SME platform [2].
References:
[1] https://m.economictimes.com/markets/ipos/fpos/medistep-healthcare-ipo-opens-today-check-gmp-issue-size-price-band-and-other-details/amp_articleshow/123178126.cms
[2] https://ipowatch.in/medistep-healthcare-ipo-date-review-price-allotment-details/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet